Core Insights - American Vanguard (AVD) reported a quarterly loss of $0.09 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.01, marking an earnings surprise of -800% [1] - The company's revenues for the quarter ended June 2024 were $128.21 million, missing the Zacks Consensus Estimate by 4.46% and down from $132.79 million a year ago [1] - The stock has underperformed significantly, losing about 28.3% since the beginning of the year compared to the S&P 500's gain of 9% [2] Company Performance - Over the last four quarters, American Vanguard has surpassed consensus EPS estimates only once [1] - The current consensus EPS estimate for the upcoming quarter is $0.10 on revenues of $150 million, and for the current fiscal year, it is $0.32 on revenues of $605.5 million [4] - The estimate revisions trend for American Vanguard is currently unfavorable, resulting in a Zacks Rank 4 (Sell) for the stock, indicating expected underperformance in the near future [4] Industry Context - The Chemical - Specialty industry, to which American Vanguard belongs, is currently in the top 43% of over 250 Zacks industries, suggesting a relatively strong industry performance [5] - The top 50% of Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1, indicating potential for better performance within the industry [5] - Another company in the same industry, Flexible Solutions International Inc. (FSI), is expected to report quarterly earnings of $0.07 per share, with revenues projected at $10.34 million, reflecting a slight increase from the previous year [5]
American Vanguard (AVD) Reports Q2 Loss, Misses Revenue Estimates